Analysts expect Enanta Pharmaceuticals Inc to report revenue of 15.50 M for Q4 26, against a range of 14.24 M to 16.75 M. The most recent reported quarter, Q3 26, came in at 14.36 M, a 8.2% miss against the 15.64 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 14.61 M | 16.96 M | 14.93 M | 18.31 M | 15.13 M | 18.61 M | 17.16 M | 14.36 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 17.83 M | 17.70 M | 15.93 M | 15.58 M | 16.56 M | 15.58 M | 17.10 M | 17.13 M | 16.75 M | 16.15 M | 15.28 M | 15.67 M | 14.82 M | 16.21 M | 16.08 M | 16.68 M | |||||||||
| Low Estimate | 15.65 M | 15.87 M | 14.68 M | 13.35 M | 13.71 M | 14.08 M | 15.99 M | 14.16 M | 14.24 M | 14.43 M | 12.95 M | 13.61 M | 13.77 M | 13.98 M | 13.82 M | 14.24 M | |||||||||
| Consensus Estimate | 16.74 M | 16.79 M | 15.31 M | 14.46 M | 15.14 M | 14.83 M | 16.54 M | 15.64 M | 15.50 M | 15.29 M | 14.11 M | 14.64 M | 14.29 M | 15.09 M | 14.95 M | 15.46 M |
Analysts expect Enanta Pharmaceuticals Inc to report earnings per share of -0.70 for Q4 26, against a range of -0.74 to -0.66. The most recent reported quarter, Q3 26, came in at -0.67, a 26.4% miss against the -0.53 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.36 | -1.05 | -1.06 | -0.85 | -0.87 | -0.42 | -0.45 | -0.67 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.00 | -1.37 | -0.99 | -0.84 | -0.99 | -0.70 | -0.49 | -0.51 | -0.66 | -0.42 | -0.42 | -0.44 | -0.55 | -0.54 | -0.65 | -0.68 | |||||||||
| Low Estimate | -1.18 | -1.49 | -1.15 | -0.92 | -1.13 | -0.76 | -0.53 | -0.55 | -0.74 | -0.46 | -0.50 | -0.50 | -0.65 | -0.64 | -0.71 | -0.80 | |||||||||
| Consensus Estimate | -1.09 | -1.43 | -1.07 | -0.88 | -1.06 | -0.73 | -0.51 | -0.53 | -0.70 | -0.44 | -0.46 | -0.47 | -0.60 | -0.59 | -0.68 | -0.74 |
Pull Wall Street consensus for Enanta Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ENTA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ENTA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ENTA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();